WallStreetZenWallStreetZen

NYSE: NVS
NOVARTIS AG Earnings & Revenue

Buy NVS

NVS past earnings growth

How has NVS's earnings growth performed historically?
Company
208.86%
Industry
95.05%
Market
75.85%
NVS's earnings have grown faster... subscribe to Premium to read more.
Earnings Growth vs Industry Performance
NVS's earnings have grown faster... subscribe to Premium to read more.
Earnings Growth vs Market Performance
NVS's earnings growth is accelerating... subscribe to Premium to read more.
Accelerating Earnings Growth Performance

NVS past revenue growth

How has NVS's revenue growth performed historically?
Company
6.24%
Industry
24.68%
Market
54.3%
NVS's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
NVS's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance
NVS's revenue growth is accelerating... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

NVS earnings and revenue history

Current Revenue
$53.0B
Current Earnings
$24.2B
Current Profit Margin
45.6%
NVS's has demonstrated consistent long-term... subscribe to Premium to read more.
Long-term Earnings Growth Trend Performance

NVS Return on Equity

Current Company
40.3%
Current Industry
42%
Current Market
38.4%
NVS's Return on Equity (40.3%)... subscribe to Premium to read more.
High Return on Equity Performance

NVS Return on Assets

Current Company
19.3%
Current Industry
10.4%
NVS is generating higher Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

NVS Return on Capital Employed

Current Company
28.48%
Current Industry
15.6%
NVS has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

NVS vs General Drug Manufacturer Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
NVS$53.00B$21.86B$24.18B+1.41%+32.27%
BMY$46.96B$17.84B$6.25B+18.66%-0.49%
AZN$41.49B$7.05B-$1.06B+13.23%N/A
MRK$53.98B$19.42B$14.18B+6.21%+28.84%
SNY$44.52B$13.07B$7.07B+4.04%+7.95%

NOVARTIS AG Earnings & Revenue FAQ

What were NVS's earnings last quarter?

NOVARTIS AG (NYSE: NVS) reported Q1 2022 earnings per share (EPS) of $1.00, up 9.89% year over year. Total NOVARTIS AG earnings for the quarter were $2.22 billion. In the same quarter last year, NOVARTIS AG's earnings per share (EPS) was $0.91.

What was NVS's earnings growth in the past year?

As of Q2 2022, NOVARTIS AG's earnings has grown 208.86% year over year. This is 113.81 percentage points higher than the US Drug Manufacturers - General industry earnings growth rate of 95.05%. NOVARTIS AG's earnings in the past year totalled $24.18 billion.

What was NVS's revenue last quarter?

NOVARTIS AG (NYSE: NVS) reported Q1 2022 revenue of $12.81 billion up 0.95% year over year. In the same quarter last year, NOVARTIS AG's revenue was $12.69 billion.

What was NVS's revenue growth in the past year?

As of Q2 2022, NOVARTIS AG's revenue has grown 6.24% year over year. This is 18.44 percentage points lower than the US Drug Manufacturers - General industry revenue growth rate of 24.68%. NOVARTIS AG's revenue in the past year totalled $53.00 billion.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.